Zacks Research Issues Negative Estimate for Revvity Earnings

Revvity Inc. (NYSE:RVTY) – Zacks Research lowered their Q3 2025 earnings per share estimates for Revvity in a research report issued on Wednesday, September 3rd. Zacks Research analyst Team now forecasts that the company will post earnings per share of $1.14 for the quarter, down from their prior estimate of $1.26. The consensus estimate for Revvity’s current full-year earnings is $4.94 per share. Zacks Research also issued estimates for Revvity’s Q4 2025 earnings at $1.53 EPS, FY2025 earnings at $4.86 EPS, Q1 2026 earnings at $1.12 EPS, Q3 2026 earnings at $1.30 EPS, Q4 2026 earnings at $1.61 EPS, FY2026 earnings at $5.35 EPS, Q1 2027 earnings at $1.25 EPS, Q2 2027 earnings at $1.49 EPS and FY2027 earnings at $6.08 EPS.

RVTY has been the topic of a number of other reports. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 3rd. Bank of America lowered their target price on Revvity from $116.00 to $110.00 and set a “buy” rating on the stock in a research note on Thursday, June 26th. Stifel Nicolaus lowered their target price on Revvity from $120.00 to $110.00 and set a “hold” rating on the stock in a research note on Tuesday, July 29th. Raymond James Financial restated an “outperform” rating and issued a $115.00 target price (down from $120.00) on shares of Revvity in a research note on Tuesday, July 29th. Finally, Evercore ISI lowered their target price on Revvity from $116.00 to $115.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 8th. Ten analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Revvity has a consensus rating of “Moderate Buy” and an average target price of $120.07.

Revvity Stock Performance

Shares of Revvity stock opened at $86.50 on Thursday. The business’s fifty day simple moving average is $93.06 and its 200 day simple moving average is $97.24. The firm has a market capitalization of $10.04 billion, a P/E ratio of 36.65, a price-to-earnings-growth ratio of 2.30 and a beta of 0.94. Revvity has a 12 month low of $81.36 and a 12 month high of $129.50. The company has a current ratio of 3.33, a quick ratio of 2.75 and a debt-to-equity ratio of 0.43.

Revvity (NYSE:RVTY) last announced its earnings results on Monday, July 28th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.14 by $0.04. The company had revenue of $720.28 million for the quarter, compared to analysts’ expectations of $711.26 million. Revvity had a return on equity of 7.66% and a net margin of 10.19%.Revvity’s quarterly revenue was up 4.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.22 earnings per share. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS.

Revvity Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 7th. Stockholders of record on Friday, October 17th will be given a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio is presently 11.86%.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. CYBER HORNET ETFs LLC acquired a new stake in shares of Revvity in the 2nd quarter valued at $32,000. MUFG Securities EMEA plc acquired a new position in Revvity during the second quarter worth about $34,000. Vermillion Wealth Management Inc. acquired a new position in shares of Revvity in the fourth quarter valued at approximately $41,000. UMB Bank n.a. increased its position in Revvity by 138.8% during the second quarter. UMB Bank n.a. now owns 406 shares of the company’s stock worth $39,000 after purchasing an additional 236 shares during the last quarter. Finally, CVA Family Office LLC increased its position in Revvity by 79.0% during the second quarter. CVA Family Office LLC now owns 410 shares of the company’s stock worth $40,000 after purchasing an additional 181 shares during the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.